Medigoxin: Difference between revisions
m (Robot: Automated text replacement (-{{SIB}} + & -{{EH}} + & -{{EJ}} + & -{{Editor Help}} + & -{{Editor Join}} +)) |
Rabin Bista (talk | contribs) No edit summary |
||
| (4 intermediate revisions by 2 users not shown) | |||
| Line 18: | Line 18: | ||
| routes_of_administration= | | routes_of_administration= | ||
}} | }} | ||
__NOTOC__ | |||
{{SI}} | {{SI}} | ||
{{CMG}} | {{CMG}} | ||
==Overview== | |||
'''Metildigoxin''' ([[International Nonproprietary Name|INN]], or '''medigoxin''' [[British Approved Name|BAN]], or '''methyldigoxin''') is a [[cardiac glycoside]], a type of drug that can be used in the treatment of [[congestive heart failure]] and [[cardiac arrhythmia]] (irregular heartbeat). The substance is closely related to [[digoxin]]; it differs from the latter only by an O-[[methyl]] group on the terminal [[monosaccharide]]. | |||
== | ==References== | ||
{{reflist|2}} | |||
{{Cardiac glycosides}} | {{Cardiac glycosides}} | ||
| Line 30: | Line 33: | ||
[[Category:Antiarrhythmic agents]] | [[Category:Antiarrhythmic agents]] | ||
[[Category:Cardenolides]] | [[Category:Cardenolides]] | ||
[[Category: | [[Category:Drug]] | ||
Latest revision as of 18:49, 15 April 2015
 | |
| Clinical data | |
|---|---|
| ATC code | |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| E number | {{#property:P628}} |
| ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
| Chemical and physical data | |
| Formula | C42H66O14 |
| Molar mass | 794.965 |
|
WikiDoc Resources for Medigoxin |
|
Articles |
|---|
|
Most recent articles on Medigoxin |
|
Media |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Medigoxin at Clinical Trials.gov Clinical Trials on Medigoxin at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Medigoxin
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Medigoxin Discussion groups on Medigoxin Directions to Hospitals Treating Medigoxin Risk calculators and risk factors for Medigoxin
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Medigoxin |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Metildigoxin (INN, or medigoxin BAN, or methyldigoxin) is a cardiac glycoside, a type of drug that can be used in the treatment of congestive heart failure and cardiac arrhythmia (irregular heartbeat). The substance is closely related to digoxin; it differs from the latter only by an O-methyl group on the terminal monosaccharide.
References
- Pages with script errors
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Chemical articles with unknown parameter in Infobox drug
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Cardiac glycosides
- Antiarrhythmic agents
- Cardenolides
- Drug